Acta Gastro-Enterologica Belgica, cilt.70, sa.1, ss.20-24, 2007 (SCI-Expanded)
Background and study aims : To investigate the efficacy of the combined therapy of lamivudine (LAM) plus alpha interferon (IFN) and LAM monotherapy in HBeAg negative chronic hepatitis B (CHB) patients who were unresponsive to previous IFN monotherapy, and the incidence of YMDD mutations.